Elena Koundourakis, PhD, discusses phase 3 trial improvements in cognition, REM normalization, and nighttime sleep quality in patients with narcolepsy.
Elena Koundourakis, PhD
Advertisement
Elena Kounourakis, PhD, head of orexin franchise development & neuroscience programs, Takeda.
Articles by Elena Koundourakis, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
3
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
4
Monoclonal Antibodies Had Varying Efficacy in Treating MG
5